Ghulam J. Mufti

Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation

C. Craddock, A. Ho, P. Mahendra, 2005, Bone Marrow Transplantation.

Non-myeloablative stem cell transplantation for congenital immunodeficiencies.

P. Veys, P. Amrolia, A. Pagliuca, 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Nonmyeloablative stem cell transplantation for congenital immunodeficiencies.

G. Mieli-Vergani, P. Veys, P. Amrolia, 2000, Blood.

Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease

G. Mufti, Z. Lim, A. Ho, 2008, Bone Marrow Transplantation.

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

G. Mufti, N. Kröger, M. Robin, 2017, Bone Marrow Transplantation.

Complement abnormalities in acquired lipodystrophy revisited.

Kenneth G. C. Smith, S. O’Rahilly, M. Clatworthy, 2009, The Journal of clinical endocrinology and metabolism.

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

N. Russell, J. Snowden, P. Veys, 2014, Bone Marrow Transplantation.

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

G. Mufti, R. Brand, Z. Lim, 2010, Bone Marrow Transplantation.

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

G. Mufti, C. Craddock, M. Labopin, 2013, Bone Marrow Transplantation.

Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)

G. Mufti, K. Ramasamy, R. Grundy, 2006, Bone Marrow Transplantation.

False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience.

G. Mufti, Z. Lim, A. Ho, 2007, The Journal of infection.

Sclerodermatous graft‐versus‐host disease: clinical spectrum and therapeutic challenges

J. Salisbury, G. Mufti, D. Creamer, 2007, The British journal of dermatology.